p38 MAPK activity is stimulated by vascular endothelial growth factor receptor 2 activation and is essential for shear stress-induced angiogenesis

Eric Gee; Malgorzata Milkiewicz; Tara L. Haas

doi:10.1002/jcp.21924

p38 MAPK activity is stimulated by vascular endothelial growth factor receptor 2 activation and is essential for shear stress-induced angiogenesis

Journal of Cellular Physiology ◽

10.1002/jcp.21924 ◽

2010 ◽

Vol 222 (1) ◽

pp. 120-126 ◽

Cited By ~ 54

Author(s):

Eric Gee ◽

Malgorzata Milkiewicz ◽

Tara L. Haas

Keyword(s):

Vascular Endothelial Growth Factor ◽

Shear Stress ◽

Growth Factor ◽

P38 Mapk ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Mapk Activity ◽

Endothelial Growth Factor

Download Full-text

Fluid shear stress-induced transcriptional activation of the vascular endothelial growth factor receptor-2 gene requires Sp1-dependent DNA binding

FEBS Letters ◽

10.1016/s0014-5793(02)03879-6 ◽

2002 ◽

Vol 535 (1-3) ◽

pp. 87-93 ◽

Cited By ~ 48

Author(s):

Carmen Urbich ◽

Monika Stein ◽

Kerstin Reisinger ◽

Roland Kaufmann ◽

Stefanie Dimmeler ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Shear Stress ◽

Growth Factor ◽

Dna Binding ◽

Transcriptional Activation ◽

Fluid Shear Stress ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Fluid Shear ◽

Endothelial Growth Factor

Download Full-text

Shear Stress Induces Expression of Vascular Endothelial Growth Factor Receptor Flk-1/KDR Through the CT-Rich Sp1 Binding Site

Arteriosclerosis Thrombosis and Vascular Biology ◽

10.1161/01.atv.0000018300.43492.83 ◽

2002 ◽

Vol 22 (6) ◽

pp. 907-913 ◽

Cited By ~ 46

Author(s):

Takeo Abumiya ◽

Toshiyuki Sasaguri ◽

Yoji Taba ◽

Yoshikazu Miwa ◽

Megumi Miyagi

Keyword(s):

Vascular Endothelial Growth Factor ◽

Shear Stress ◽

Growth Factor ◽

Binding Site ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Download Full-text

Vascular Endothelial Growth Factor Receptor Blockade by SU5416 Combined With Pulsatile Shear Stress Causes Apoptosis and Subsequent Proliferation of Apoptosis-Resistant Endothelial Cells

CHEST Journal ◽

10.1378/chest.128.6_suppl.610s-a ◽

2005 ◽

Vol 128 (6) ◽

pp. 610S-611S ◽

Cited By ~ 12

Author(s):

Seiichiro Sakao ◽

Laimute Taraseviciene-Stewart ◽

Jong Deog Lee ◽

Kathy Wood ◽

Carlyne D. Cool ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Endothelial Cells ◽

Shear Stress ◽

Growth Factor ◽

Growth Factor Receptor ◽

Receptor Blockade ◽

Vascular Endothelial ◽

Pulsatile Shear Stress ◽

Endothelial Growth Factor

Download Full-text

299 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2-INHIBITION PREVENTS ENDOTHELIAL SUSCEPTIBILITY TO TNF-a UNDER CHRONIC NON-UNIFORM SHEAR STRESS

Atherosclerosis Supplements ◽

10.1016/s1567-5688(11)70300-2 ◽

2011 ◽

Vol 12 (1) ◽

pp. 65

Author(s):

K. Urschel ◽

W.G. Daniel ◽

C.D. Garlichs ◽

I. Cicha

Keyword(s):

Vascular Endothelial Growth Factor ◽

Shear Stress ◽

Growth Factor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Uniform Shear ◽

Endothelial Growth Factor

Download Full-text

Fortgeschrittenes medulläres Schilddrüsenkarzinom: Vandetanib verbessert das progressionsfreie Überleben

Onkologische Welt ◽

10.1055/s-0038-1631032 ◽

2012 ◽

Vol 03 (02) ◽

pp. 93-92

Author(s):

Alexander Kretzschmar

Keyword(s):

Vascular Endothelial Growth Factor ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Phase Iii ◽

Vascular Endothelial ◽

Medulläres Schilddrüsenkarzinom ◽

Epidermal Growth ◽

Endothelial Growth Factor

Vandetanib ist ein oraler Hemmer des RET-Kinase-, VEGF (Vascular Endothelial Growth Factor Receptor)- und EGFR (Epidermal Growth Factor Receptor)-Signalwegs. In einer zulassungsrelevanten, randomisierten, doppelblinden, placebokontrollierten Phase- III-Studie verlängerte der Tyrosinkinasehemmer das progressionsfreie Überleben (PFS) signifikant länger als Placebo.

Download Full-text

Expression des „Epidermal Growth-Factor Receptor“ (EGFR) und des „Vascular Endothelial Growth Factor“ (VEGF) bei Lymphangioleiomyomatose (LAM)

Pneumologie ◽

10.1055/s-2006-934022 ◽

2006 ◽

Vol 60 (S 1) ◽

Author(s):

H Watz ◽

K Engels ◽

M Amthor ◽

D Kirsten ◽

H Magnussen

Keyword(s):

Vascular Endothelial Growth Factor ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Epidermal Growth ◽

Endothelial Growth Factor

Download Full-text

Faculty Opinions recommendation of Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1163678.625451 ◽

2009 ◽

Author(s):

David Bates

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Lymphatic Vessel ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endogenous Inhibitor ◽

Vessel Growth ◽

Alternatively Spliced ◽

Endothelial Growth Factor

Download Full-text

Faculty Opinions recommendation of Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.11744956.12828054 ◽

2011 ◽

Author(s):

Asma Nusrat

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Receptor Antagonism ◽

Endothelial Growth Factor ◽

Α2β1 Integrin

Download Full-text

Faculty Opinions recommendation of Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.11744956.13740054 ◽

2011 ◽

Author(s):

Richard L Stevens

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Receptor Antagonism ◽

Endothelial Growth Factor ◽

Α2β1 Integrin

Download Full-text

Faculty Opinions recommendation of 111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenib.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717697854.793153053 ◽

2012 ◽

Author(s):

Hendrik van Poppel ◽

Yuri Tolkach

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Renal Cell Cancer ◽

Renal Cell ◽

Cell Cancer ◽

Neoadjuvant Treatment ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor ◽

Receptor Inhibitor

Download Full-text